MuscleBlaze has gained the trust of people over the years and has been providing them with amazing products
Can I take Calcium and Esomeprazole together
- Kurt thought there was a 50% chance all GLP-1 compounding would end in the next 6 months (both 503A and 503B) - Did not mention direct communication from the FDA telling them to stop compounding GLP-1s - ProRx felt it was time to stop due to the end of the shortage in March 2025, and did not feel influenced by the April 1 FDA statement - Kurt thinks 503B production of GLP-1s are underreported and much larger than thought - 503As can't take care of the compounded GLP-1 market at their current capacity - We both have concerns about patient access without compounded GLP-1s and worry it will send more patients to the grey market for RUO injections that don't have the same level of sterility and regulation To view or add a comment, sign in Yesterday the FDA proposed removing GLP-1s from the 503B bulk list, and I spoke to Kurt Lunkwitz from ProRx to talk about changes to GLP-1 compounding

Beyond its approved indication, research has explored PT-141s MC4R-mediated effects on energy homeostasis, mood, and inflammation areas relevant to the broader melanocortin receptor research literature
When they analyzed tissues from the heart and other organs, they found the cell-surface proteins targeted by GLP-1 drugs were most numerous in the pancreas, which one would expect given the drugs benefit in diabetes
Medicare Part D covers the rest under the bridge benefit